CRHR1 anticorps (AA 107-117)

N° du produit ABIN238557

Détail du produit anti-CRHR1 anticorps

Antigène: CRHR1 (Corticotropin Releasing Hormone Receptor 1 (CRHR1))

Épitope: AA 107-117

Reactivité: Humain, Souris, Rat

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp CRHR1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Fonction: CRHR1 / CRF-R (aa 107 - 117)

Séquence: NEEKKSKVHY H

Réactivité croisée: Humain, Souris, Rat

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Classe de qualité: Verified

Immunogène: Peptide with sequence C-NEEKKSKVHYH, from the internal region of the protein sequence according to NP_004373.2.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Approx 60 kDa band observed in Human Brain (Cerebellum), Colon, Rat Brain and Mouse spinal cord lysates (calculated MW of 47.7 kDa according to NP_004373.2). The observed molecular weight corresponds to earlier findings in literature with di

Peptide ELISA: antibody detection limit dilution 1:128000.

Commentaires:

Immunofluorescence: Expression of the protein seen in the membranes, vesicles and cytoplasm of MCF7 and Neuro2a cells. Recommended concentration: 10μg/ml.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Références pour anticorps anti-CRHR1 (ABIN238557)

Xie, Penzes, Srivastava: "Exchange protein directly activated by cAMP 2 is required for corticotropin-releasing hormone-mediated spine loss." dans: The European journal of neuroscience, Vol. 50, Issue 7, pp. 3108-3114, (2020) (PubMed).

Jüngling, Liu, Lesting, Coulon, Sosulina, Reinscheid, Pape: "Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor." dans: The Journal of physiology, Vol. 590, Issue Pt 16, pp. 3701-17, (2012) (PubMed).

Weerachayaphorn, Mennone, Soroka, Harry, Hagey, Kensler, Boyer: "Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine." dans: American journal of physiology. Gastrointestinal and liver physiology, Vol. 302, Issue 9, pp. G925-36, (2012) (PubMed).

Détails sur CRHR1

Antigène: CRHR1 (Corticotropin Releasing Hormone Receptor 1 (CRHR1))

Autre désignation: CRHR1 (CRHR1 Produits)

Synonymes: anticorps CRF-R, anticorps CRF-R-1, anticorps CRF-R1, anticorps CRF1, anticorps CRFR-1, anticorps CRFR1, anticorps CRH-R-1, anticorps CRH-R1, anticorps CRH-R1h, anticorps CRHR, anticorps CRHR1L, anticorps CRHR1f, anticorps Crhr, anticorps crhr1, anticorps crhr1-A, anticorps CRHR1, anticorps CRHR1-IT1-CRHR1, anticorps MGC57346-CRHR1, anticorps corticotropin releasing hormone receptor 1, anticorps corticotropin releasing hormone receptor 1, gene 2 S homeolog, anticorps corticotropin-releasing factor receptor 1, anticorps LINC02210-CRHR1 readthrough, anticorps CRHR1, anticorps Crhr1, anticorps crhr1.2.S, anticorps LOC610380, anticorps LOC100065598, anticorps LINC02210-CRHR1, anticorps crhr1

Sujet: CRHR1, CRF-R, corticotropin releasing hormone receptor 1, CRF1, CRFR1, CRH-R1h, CRHR, CRHR1f, corticotropin releasing hormone receptor variant 1h, seven transmembrane helix receptor

ID gène: 1394, 12921, 58959

NCBI Accession: NP_004373

Pathways: Hormone Transport, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Feeding Behaviour, Negative Regulation of Transporter Activity